Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
University of California, San Diego
University of California, San Diego
Memorial Sloan Kettering Cancer Center
Nova Scotia Health Authority
University of Texas Southwestern Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Iowa
Dana-Farber Cancer Institute
Icahn School of Medicine at Mount Sinai
University of Zurich
Roswell Park Cancer Institute
University of Leipzig
University of Alabama at Birmingham
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Chicago
Roswell Park Cancer Institute
Groupe Oncologie Radiotherapie Tete et Cou
National Center for Complementary and Integrative Health (NCCIH)